Well it looks like investors will be able to VALIDATE it when the disclosure is released.
However, the best defenses against short-selling are strong fundamentals, which Healthnostics' unfolding business plan continues to support. This will be validated when the Initial Information and Disclosure Document for filing on the OTC Market reporting system is filed later this quarter.